10:05am ET
Health and Healthcare
Short Sellers Hike Their Bets in Major Biotechs
The August 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Companies
/Healthcare
Gilead Sciences Inc
$148.09
▼ $0.68 (−0.46%) today
Markets closed · 10:24pm ET
GILD Coverage
Page 87:55am ET
Health and Healthcare
5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five…
3:50pm ET
Health and Healthcare
Why This Gilead Deal Is Huge For Jounce Therapeutics
Jounce Therapeutics Inc. (NASDAQ: JNCE) made a massive gain on Tuesday after the company announced a licensing agreement with Gilead Sciences Inc. (NASDAQ: GILD). This deal is for the discovery and development…
10:13am ET
Health and Healthcare
Major Biotechs Scare Off Short Sellers
The August 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
10:25am ET
Health and Healthcare
The FDA Comes Down on Gilead and Galapagos With CRL
The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.
9:02am ET
Investing
Top Analyst Upgrades and Downgrades: Agilent, Cree, Deere, Disney, Gilead, Home Depot, Kohl’s, Nordstrom, Walmart and More
Wednesday's top analyst upgrades and downgrades included Agilent Technologies, Cree, Deere, Gilead Sciences, Home Depot, Kohl's, Nordstrom, Walmart and Walt Disney.
8:25am ET
Health and Healthcare
Short Sellers Shy Away From Big Biotech
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
10:07am ET
Health and Healthcare
5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may…
9:41am ET
Health and Healthcare
Big Biotechs Scare Off Short Sellers
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
6:31am ET
Health and Healthcare
AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
9:09am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More
Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with what is still a very deep recession, investors need to be considering…
8:25am ET
Investing
7 Unpopular Value Stocks That Could Surge Into 2021
The run-up in equity prices related to the COVID-19 outbreak combined with the federal government's efforts to soften the financial damage due to the pandemic have driven equity prices sharply higher. Inevitably,…
9:43am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Biotechs
The June 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
10:31am ET
Health and Healthcare
Gilead Moves Forward With Pricing Its COVID-19 Treatment
Gilead has priced its COVID-19 drug candidate at $2,340 for a five-day treatment in the United States and some other developed countries. The company set the price for a single vial of…
Chris Lange 9:46am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.